Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-25 @ 2:00 AM
NCT ID:
NCT01763294
Eligibility Criteria:
Inclusion Criteria:
* any gender
* age ≥ 15 and \<65 years
* Refractory epilepsy characterized by 3 or more seizures by month and the right use of 2 or more antiepileptic drugs during the last 12 months
* Not eligible for surgery treatment
* Right attachment to the antiepileptic treatment established at least 12 months before the date of inclusion
* Multifocal epilepsy defined as 2 or more lobar regions affected with epileptic activity
Exclusion Criteria:
* Patients with pseudoseizures
* Previous craniotomy
* Active local infection of the skull
* Informed consent not signed
* Patients with generalized idiopathic epilepsy or focal idiopathic epilepsy
* Patients in stupor or coma
* Patients in lactation or pregnancy
* Patients with chronic degenerative diseases of the nervous system
* Patients with exacerbated chronic degenerative diseases
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
65 Years
Study:
NCT01763294
Study Brief:
Protocol Section:
NCT01763294